1. Natural Products as Anticancer Agents: Current Status and Future Perspectives
   Abid Naeem et al, 2022, Molecules CrossRef
2. Biodiversity, Chemodiversity, and Pharmacotherapy of Anemone Medicinal Plants
   Da-Cheng Hao, 2019, Ranunculales Medicinal Plants CrossRef
3. Therapeutic potential of natural products in glioblastoma treatment: targeting key glioblastoma signaling pathways and epigenetic alterations
   M. N. Abbas et al, 2020, Clinical and Translational Oncology CrossRef
4. Anticancer Chemodiversity of Ranunculaceae Medicinal Plants
   Da-Cheng Hao, 2019, Ranunculales Medicinal Plants CrossRef
5. CRM197 in Combination With shRNA Interference of VCAM-1 Displays Enhanced Inhibitory Effects on Human Glioblastoma Cells
   Yi Hu et al, 2015, Journal of Cellular Physiology CrossRef
6. Reduction of SCUBE3 by a new marine-derived asterosaponin leads to arrest of glioma cells in G1/S
   Peng-Cheng Qiu et al, 2020, Oncogenesis CrossRef
7. Saponin 6 derived from Anemone taipaiensis induces U87 human malignant glioblastoma cell apoptosis via regulation of Fas and Bcl-2 family proteins
   CHEN-CHEN JI et al, 2016, Molecular Medicine Reports CrossRef
8. Anemone medicinal plants: ethnopharmacology, phytochemistry and biology
   Da-Cheng Hao et al, 2017, Acta Pharmaceutica Sinica B CrossRef
9. CN‐3 increases TMZ sensitivity and induces ROS‐dependent apoptosis and autophagy in TMZ‐resistance glioblastoma
   Yu‐Ye Xue et al, 2022, Journal of Biochemical and Molecular Toxicology CrossRef
10. Natural products: a hope for glioblastoma patients
    Raghupathy Vengoji et al, 2018, Oncotarget CrossRef
11. Medicinal Plants for Glioblastoma Treatment
    Shreeja Datta et al, 2022, Anti-Cancer Agents in Medicinal Chemistry CrossRef